CAJ | 학술논문

目的：比较经皮射频消融术（ RFA）与微波消融术（ MWA）治疗肝癌的可行性和安全性。方法110例肝癌患者，分为两组，50例患者接受经皮射频消融术，60例接受微波消融术。比较射频组和微波组的生存率、肿瘤消融率、局部复发率、并发症发生率。结果射频组和微波组的1、3、5年累积生存率分别为96．2％、74．1％、63．4％，94．2％、70．5％、61．7％；肿瘤消融率射频组为98．3％，微波组为97．7％；局部复发率分别为12．0％和15．0％；并发症发生率分别为6．0％和8．3％。结论经皮射频消融术与微波消融术治疗肝癌的治疗效果无明显差异，在临床治疗中具有安全性和有效性。
목적：비교경피사빈소융술（ RFA）여미파소융술（ MWA）치료간암적가행성화안전성。방법110례간암환자，분위량조，50례환자접수경피사빈소융술，60례접수미파소융술。비교사빈조화미파조적생존솔、종류소융솔、국부복발솔、병발증발생솔。결과사빈조화미파조적1、3、5년루적생존솔분별위96．2％、74．1％、63．4％，94．2％、70．5％、61．7％；종류소융솔사빈조위98．3％，미파조위97．7％；국부복발솔분별위12．0％화15．0％；병발증발생솔분별위6．0％화8．3％。결론경피사빈소융술여미파소융술치료간암적치료효과무명현차이，재림상치료중구유안전성화유효성。
Objective To compare the feasibility and safety of percutaneous radiofrequency ablation ( PRFA) and mi-crowave ablation ( MWA) for liver cancer.Methods 110 cases of patients with liver cancer were divided into 2 groups,50 pa-tients received PRFA,60 patients received MWA.The survival rate,tumor ablation rate,local recurrence rate,and complications between the 2 groups were compared.Results In PRFA group and MWA group,1-,3-and 5-year cumulative survival rates were 96.2%,74.1%,63.4%,and 94.2%,70.5%,61.7%;tumor ablation rates were 98.3% and 97.7%;local recurrence rates were 12%and 15%;the rate of complications were 6.0%and 8.3%respectively.Conclusion PRFA and MWA for hepatocel-lular carcinoma have similar therapeutic effects,and safety and effectiveness in the clinical treatment.